FDA recall record

VistaPharm NYSTATIN ORAL SUSPENSION, USP 100,000 units per mL Contains: Alcohol 0.5% v/v recall — FDA D-0019-2021

Failed Impurties/Degradation Specifications: out of specification results for an impurity for one lot

Class IIIclassification
D-0019-2021official record ID
Oct 14, 2020report date

Recall record at a glance

Official recordD-0019-2021
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmVistaPharm, Inc.
Report dateOct 14, 2020
Recall initiation dateSep 25, 2020
Quantity14,244 16 oz bottles
LocationLargo, FL, United States

Official product description

NYSTATIN ORAL SUSPENSION, USP 100,000 units per mL Contains: Alcohol 0.5% v/v (Bubblegum Flavored) 16 fl. oz. (480 mL) Manufactured by: VistaPharm, Inc. Largo FL 33771, USA NDC 66689-008-16 UPC 6668900816,

Why the product was recalled

Failed Impurties/Degradation Specifications: out of specification results for an impurity for one lot

Distribution information

Distributed Nationwide in the USA including Puerto Rico

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.